Spruce Biosciences, Inc. Common Stock (SPRB) — Long-term Investment Intensity
Spruce Biosciences, Inc. Common Stock (SPRB) has a Long-term Investment Intensity of 5.6% as of June 2022. Long-term investments of $5.80 Million represent 5.6% of total assets of $104.52 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Spruce Biosciences, Inc. Common Stock reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Spruce Biosciences, Inc. Common Stock Long-term Investment Intensity (2021–2021)
This chart shows how Spruce Biosciences, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of June 2022, the intensity stands at 5.6%, reflecting long-term investments of $5.80 Million against total assets of $104.52 Million USD. Explore debt repayment capacity of Spruce Biosciences, Inc. Common Stock to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Spruce Biosciences, Inc. Common Stock (2021–2021)
The table below presents the year-by-year Long-term Investment Intensity for Spruce Biosciences, Inc. Common Stock from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Spruce Biosciences, Inc. Common Stock worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 25.7% | $32.46 Million | $126.49 Million | — |